(Q45517703)

14 December 2017

title

Evaluation of feline immunodeficiency virus ORF-A mutants as candidate attenuated vaccine (English)

1 reference

feline immunodeficiency virus

14 December 2017

1 reference

object named as

feline immunodeficiency virus

1 reference

Pistello M

1

1 reference

14 December 2017

Bonci F

2

1 reference

14 December 2017

Isola P

3

1 reference

14 December 2017

Mazzetti P

4

1 reference

14 December 2017

Merico A

5

1 reference

14 December 2017

Zaccaro L

6

1 reference

14 December 2017

Matteucci D

7

1 reference

14 December 2017

Bendinelli M

8

1 reference

14 December 2017

language of work or name

English

0 references

publication date

1 February 2005

1 reference

14 December 2017

1 reference

14 December 2017

volume

332

1 reference

14 December 2017

issue

2

1 reference

14 December 2017

page(s)

676-690

1 reference

Simian-human immunodeficiency virus SHIV89.6-induced protection against intravaginal challenge with pathogenic SIVmac239 is independent of the route of immunization and is associated with a combination of cytotoxic T-lymphocyte and alpha interferon

14 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.004

Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.004

Construction and in vitro characterization of attenuated feline immunodeficiency virus long terminal repeat mutant viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.004

Simian immunodeficiency virus promoter exchange results in a highly attenuated strain that protects against uncloned challenge virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.004

Rapid clearance of virus after acute HIV-1 infection: correlates of risk of AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.004

Live attenuated HIV vaccines: predicting the tradeoff between efficacy and safety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.004

Simian immunodeficiency virus replicates to high levels in naturally infected African green monkeys without inducing immunologic or neurologic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.004

Transmission and immunopathogenesis of FIV in cats as a model for HIV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.004

A truncated form of Nef selected during pathogenic reversion of simian immunodeficiency virus SIVmac239Deltanef increases viral replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.004

Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.004

Control of HIV-1 infection by soluble factors of the immune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.004

Lessons from the cat: feline immunodeficiency virus as a tool to develop intervention strategies against human immunodeficiency virus type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.004

Suppression of feline immunodeficiency virus replication in vitro by a soluble factor secreted by CD8+ T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.004

Progressive expansion of an L-selectin-negative CD8 cell with anti-feline immunodeficiency virus (FIV) suppressor function in the circulation of FIV-infected cats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.004

Feline immunodeficiency virus ORF-Ais required for virus particle formation and virus infectivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.004

Feline immunodeficiency virus Orf-A localizes to the nucleus and induces cell cycle arrest

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.004

Feline immunodeficiency virus-infected cat sera associated with the development of broad neutralization resistance in vivo drive similar reversions in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.004

Live attenuated, nef-deleted SIV is pathogenic in most adult macaques after prolonged observation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.004

Vaccination with inactivated virus but not viral DNA reduces virus load following challenge with a heterologous and virulent isolate of feline immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.004

The roles of vif and ORF-A genes and AP-1 binding site in in vivo replication of feline immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.004

Protective immunity induced by live attenuated simian immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.004

Persistence of pathogenic challenge virus in macaques protected by simian immunodeficiency virus SIVmacDeltanef

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.004

Immunization of macaques with live simian human immunodeficiency virus (SHIV) vaccines conferred protection against AIDS induced by homologous and heterologous SHIVs and simian immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.004

Immunization for long-term protection against AIDS using the macaque model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.004

Using SHIVs to develop an anti-HIV-1 live-attenuated vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.004

Characterization of simian and human immunodeficiency chimeric viruses re-isolated from vaccinated macaque monkeys after challenge infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.004

High beta-chemokine expression levels in lymphoid tissues of simian/human immunodeficiency virus 89.6-vaccinated rhesus macaques are associated with uncontrolled replication of simian immunodeficiency virus challenge inoculum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.004

Immunopathogenesis and immunotherapy in AIDS virus infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.004

Prospects for vaccine protection against HIV-1 infection and AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.004

Protective immunity against feline immunodeficiency virus induced by inoculation with vif-deleted proviral DNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.004

AIDS vaccination studies using feline immunodeficiency virus as a model: immunisation with inactivated whole virus suppresses viraemia levels following intravaginal challenge with infected cells but not following intravenous challenge with cell-free

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.004

Live attenuated HIV vaccines: a proposal for further research and development.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.004

Quintuple deglycosylation mutant of simian immunodeficiency virus SIVmac239 in rhesus macaques: robust primary replication, tightly contained chronic infection, and elicitation of potent immunity against the parental wild-type strain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.004

7 January 2021

HIV vaccine strategies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.004

Simian immunodeficiency virus-specific cytotoxic T lymphocytes and protection against challenge in rhesus macaques immunized with a live attenuated simian immunodeficiency virus vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.004

The role of inducer cells in mediating in vitro suppression of feline immunodeficiency virus replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.004

Development of feline immunodeficiency virus ORF-A (tat) mutants: in vitro and in vivo characterization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.004

AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: protection from an intraclade challenge administered systemically or mucosally by an attenuated vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.004

Pathogenic conversion of live attenuated simian immunodeficiency virus vaccines is associated with expression of truncated Nef

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.004

Live, attenuated simian immunodeficiency virus SIVmac-M4, with point mutations in the Env transmembrane protein intracytoplasmic domain, provides partial protection from mucosal challenge with pathogenic SIVmac251.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.004

Replication, Immunogenicity, and Protective Properties of Live-Attenuated Simian Immunodeficiency Viruses Expressing Interleukin-4 or Interferon-γ

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.004

Mechanisms of protection induced by attenuated simian immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.004

Nucleotide sequence and genomic organization of feline immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.004

Temporal patterns of feline immunodeficiency virus transcripts in peripheral blood cells during the latent stage of infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.004

FIV vaccine development and its importance to veterinary and human medicine: a review FIV vaccine 2002 update and review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.004

Feline immunodeficiency virus infection phenotypically and functionally activates immunosuppressive CD4+CD25+ T regulatory cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.004

Domestic cats infected with lion or puma lentivirus develop anti-feline immunodeficiency virus immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.004

Immunization of newborn rhesus macaques with simian immunodeficiency virus (SIV) vaccines prolongs survival after oral challenge with virulent SIVmac251.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.004

Preclinical AIDS vaccine research: survey of SIV, SHIV, and HIV challenge studies in vaccinated nonhuman primates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.004

Influence of ORF2 on host cell tropism of feline immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.004

Live attenuated HIV vaccines: pitfalls and prospects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.004

FIV infection of the domestic cat: an animal model for AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.004

Development of IL-2 Independent Feline Lymphoid Cell Lines Chronically Infected with Feline Immunodeficiency Virus: Importance for Diagnostic Reagents and Vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.004

Demonstration that orf2 encodes the feline immunodeficiency virus transactivating (Tat) protein and characterization of a unique gene product with partial rev activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.004

inferred from DOI database lookup

7 January 2021

based on heuristic

Kinetics of replication of a partially attenuated virus and of the challenge virus during a three-year intersubtype feline immunodeficiency virus superinfection experiment in cats

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.004

inferred from DOI database lookup

7 January 2021

based on heuristic

Enhancement of feline immunodeficiency virus (FIV) infection after DNA vaccination with the FIV envelope

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.12.004

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2004.12.004

1 reference

14 December 2017

1 reference